200 related articles for article (PubMed ID: 27553209)
1. The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes.
Peasgood T; Brennan A; Mansell P; Elliott J; Basarir H; Kruger J
Med Decis Making; 2016 Nov; 36(8):1020-33. PubMed ID: 27553209
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in type 1 diabetes mellitus pediatric patients and their caregivers in Spain: an observational cross-sectional study.
López-Bastida J; López-Siguero JP; Oliva-Moreno J; Vázquez LA; Aranda-Reneo I; Reviriego J; Dilla T; Perez-Nieves M
Curr Med Res Opin; 2019 Sep; 35(9):1589-1595. PubMed ID: 30964364
[No Abstract] [Full Text] [Related]
3. Measurement Properties of the Online EuroQol-5D-Youth Instrument in Children and Adolescents With Type 1 Diabetes Mellitus: Questionnaire Study.
Mayoral K; Rajmil L; Murillo M; Garin O; Pont A; Alonso J; Bel J; Perez J; Corripio R; Carreras G; Herrero J; Mengibar JM; Rodriguez-Arjona D; Ravens-Sieberer U; Raat H; Serra-Sutton V; Ferrer M
J Med Internet Res; 2019 Nov; 21(11):e14947. PubMed ID: 31714252
[TBL] [Abstract][Full Text] [Related]
4. Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study.
Grandy S; Fox KM;
Health Qual Life Outcomes; 2012 Aug; 10():99. PubMed ID: 22917219
[TBL] [Abstract][Full Text] [Related]
5. Temporal associations of diabetes-related complications with health-related quality of life decrements in Chinese patients with type 2 diabetes: A prospective study among 19 322 adults-Joint Asia Diabetes Evaluation (JADE) register (2007-2018).
Lui JNM; Lau ESH; Yang A; Wu H; Fu A; Lau V; Loo K; Yeung T; Yue R; Ma RCW; Kong APS; Ozaki R; Luk AOY; Chow EYK; Chan JCN
J Diabetes; 2024 Jun; 16(6):e13503. PubMed ID: 37984378
[TBL] [Abstract][Full Text] [Related]
6. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
[TBL] [Abstract][Full Text] [Related]
7. Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications.
Kontodimopoulos N; Pappa E; Chadjiapostolou Z; Arvanitaki E; Papadopoulos AA; Niakas D
Eur J Health Econ; 2012 Feb; 13(1):111-20. PubMed ID: 21132558
[TBL] [Abstract][Full Text] [Related]
8. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
[TBL] [Abstract][Full Text] [Related]
9. Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practice.
Parker M; Haycox A; Graves J
Pharmacoeconomics; 2011 Aug; 29(8):719-30. PubMed ID: 21635017
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in diabetes: The associations of complications with EQ-5D scores.
Solli O; Stavem K; Kristiansen IS
Health Qual Life Outcomes; 2010 Feb; 8():18. PubMed ID: 20132542
[TBL] [Abstract][Full Text] [Related]
11. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study.
Ismail K; Maissi E; Thomas S; Chalder T; Schmidt U; Bartlett J; Patel A; Dickens C; Creed F; Treasure J
Health Technol Assess; 2010 May; 14(22):1-101, iii-iv. PubMed ID: 20483060
[TBL] [Abstract][Full Text] [Related]
13. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?
Torrance N; Lawson KD; Afolabi E; Bennett MI; Serpell MG; Dunn KM; Smith BH
Pain; 2014 Oct; 155(10):1996-2004. PubMed ID: 25020004
[TBL] [Abstract][Full Text] [Related]
14. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.
Kontodimopoulos N; Argiriou M; Theakos N; Niakas D
Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544
[TBL] [Abstract][Full Text] [Related]
15. Estimating Quality of Life Decrements Due to Diabetes Complications in the United States: The Health Utility Index (HUI) Diabetes Complication Equation.
Shao H; Yang S; Fonseca V; Stoecker C; Shi L
Pharmacoeconomics; 2019 Jul; 37(7):921-929. PubMed ID: 30778865
[TBL] [Abstract][Full Text] [Related]
16. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
[TBL] [Abstract][Full Text] [Related]
17. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.
Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D;
Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259
[TBL] [Abstract][Full Text] [Related]
18. Putting the 'Q' in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures.
Mann R; Gilbody S; Richards D
Soc Psychiatry Psychiatr Epidemiol; 2009 Jul; 44(7):569-78. PubMed ID: 19011721
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing health-related quality of life in patients with Type 1 diabetes.
Raymakers AJN; Gillespie P; O'Hara MC; Griffin MD; Dinneen SF
Health Qual Life Outcomes; 2018 Feb; 16(1):27. PubMed ID: 29394942
[TBL] [Abstract][Full Text] [Related]
20. A comparison of four different approaches to measuring health utility in depressed patients.
Turner N; Campbell J; Peters TJ; Wiles N; Hollinghurst S
Health Qual Life Outcomes; 2013 May; 11():81. PubMed ID: 23659557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
